Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

Christine Erikstrup Hallgreen; Hendrika A. van den Ham; Shahrul Mt-Isa; Simon Ashworth; Richard Hermann; Steve Hobbiger; Davide Luciani; Alain Micaleff; Andrew Thomson; Nan Wang; Tjeerd P. van Staa; Gerald Downey; Ian Hirsch; Kimberley Hockley; Juhaeri Juhaeri; Marilyn Metcalf; Jeremiah Mwangi; Richard Nixon; Ruth Peters; Isabelle Stoeckert; Ed Waddingham; Ioanna Tzoulaki; Deborah Ashby; Lesley Wise

doi:10.1002/pds.3676

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

Christine Erikstrup Hallgreen, Hendrika A. van den Ham, Shahrul Mt-Isa, Simon Ashworth, Richard Hermann, Steve Hobbiger, Davide Luciani, Alain Micaleff, Andrew Thomson, Nan Wang, Tjeerd P. van Staa, Gerald Downey, Ian Hirsch, Kimberley Hockley, Juhaeri Juhaeri, Marilyn Metcalf, Jeremiah Mwangi, Richard Nixon, Ruth Peters, Isabelle StoeckertEd Waddingham, Ioanna Tzoulaki, Deborah Ashby, Lesley Wise

16 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	23
Udgave nummer	9
Sider (fra-til)	974-983
Antal sider	10
ISSN	1053-8569
DOI	https://doi.org/10.1002/pds.3676
Status	Udgivet - sep. 2014
Udgivet eksternt	Ja

Adgang til dokumentet

10.1002/pds.3676

Citationsformater

Hallgreen, C. E., van den Ham, H. A., Mt-Isa, S., Ashworth, S., Hermann, R., Hobbiger, S., Luciani, D., Micaleff, A., Thomson, A., Wang, N., van Staa, T. P., Downey, G., Hirsch, I., Hockley, K., Juhaeri, J., Metcalf, M., Mwangi, J., Nixon, R., Peters, R., ... Wise, L. (2014). Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology. Pharmacoepidemiology and Drug Safety, 23(9), 974-983. https://doi.org/10.1002/pds.3676

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology. / Hallgreen, Christine Erikstrup; van den Ham, Hendrika A.; Mt-Isa, Shahrul et al.
I: Pharmacoepidemiology and Drug Safety, Bind 23, Nr. 9, 09.2014, s. 974-983.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Hallgreen, CE, van den Ham, HA, Mt-Isa, S, Ashworth, S, Hermann, R, Hobbiger, S, Luciani, D, Micaleff, A, Thomson, A, Wang, N, van Staa, TP, Downey, G, Hirsch, I, Hockley, K, Juhaeri, J, Metcalf, M, Mwangi, J, Nixon, R, Peters, R, Stoeckert, I, Waddingham, E, Tzoulaki, I, Ashby, D & Wise, L 2014, 'Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology', Pharmacoepidemiology and Drug Safety, bind 23, nr. 9, s. 974-983. https://doi.org/10.1002/pds.3676

@article{333688867e634e66a62895bbe618a559,

title = "Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology",

keywords = "benefit-risk, decision making, medicines, qualitative, quantitative, warfarin, pharmacoepidemiology",

author = "Hallgreen, {Christine Erikstrup} and {van den Ham}, {Hendrika A.} and Shahrul Mt-Isa and Simon Ashworth and Richard Hermann and Steve Hobbiger and Davide Luciani and Alain Micaleff and Andrew Thomson and Nan Wang and {van Staa}, {Tjeerd P.} and Gerald Downey and Ian Hirsch and Kimberley Hockley and Juhaeri Juhaeri and Marilyn Metcalf and Jeremiah Mwangi and Richard Nixon and Ruth Peters and Isabelle Stoeckert and Ed Waddingham and Ioanna Tzoulaki and Deborah Ashby and Lesley Wise",

year = "2014",

month = sep,

doi = "10.1002/pds.3676",

language = "English",

volume = "23",

pages = "974--983",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "JohnWiley & Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

AU - Hallgreen, Christine Erikstrup

AU - van den Ham, Hendrika A.

AU - Mt-Isa, Shahrul

AU - Ashworth, Simon

AU - Hermann, Richard

AU - Hobbiger, Steve

AU - Luciani, Davide

AU - Micaleff, Alain

AU - Thomson, Andrew

AU - Wang, Nan

AU - van Staa, Tjeerd P.

AU - Downey, Gerald

AU - Hirsch, Ian

AU - Hockley, Kimberley

AU - Juhaeri, Juhaeri

AU - Metcalf, Marilyn

AU - Mwangi, Jeremiah

AU - Nixon, Richard

AU - Peters, Ruth

AU - Stoeckert, Isabelle

AU - Waddingham, Ed

AU - Tzoulaki, Ioanna

AU - Ashby, Deborah

AU - Wise, Lesley

PY - 2014/9

Y1 - 2014/9

KW - benefit-risk

KW - decision making

KW - medicines

KW - qualitative

KW - quantitative

KW - warfarin

KW - pharmacoepidemiology

U2 - 10.1002/pds.3676

DO - 10.1002/pds.3676

M3 - Journal article

C2 - 25043919

SN - 1053-8569

VL - 23

SP - 974

EP - 983

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 9

ER -

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology

Adgang til dokumentet

Fingeraftryk

Citationsformater